fbpx
August 3, 2020

FDA Approves Cannabidiol for Tuberous Sclerosis Complex FDA Approves Cannabidiol for Tuberous Sclerosis Complex

The cannabidiol (CBD) oral solution Epidiolex has been approved by the US Food and Drug Administration (FDA) for the new indication of treatment of seizures associated […]
August 3, 2020

In Epilepsy, Brain-Responsive Stimulation Passes Long-term Tests In Epilepsy, Brain-Responsive Stimulation Passes Long-term Tests

Two new long-term studies, one an extension trial and the other an analysis of real-world experience, show that the RNS System direct brain responsive neurostimulator leads […]
August 3, 2020

Delayed Driving Reactions Even After Concussion Symptoms Resolve Delayed Driving Reactions Even After Concussion Symptoms Resolve

Individuals who have experienced a concussion may not be ready to drive even after symptoms have resolved, new research from a small study suggests.  A small […]
August 3, 2020

Twelve Risk Factors Linked to 40% of World’s Dementia Cases Twelve Risk Factors Linked to 40% of World’s Dementia Cases

Modifying 12 risk factors over the life course could delay or prevent 40% of dementia cases, a new report suggests. The report is an update of […]
August 1, 2020

‘Long Sleep’ or Apnea in Middle Age Double Risk For AD ‘Long Sleep’ or Apnea in Middle Age Double Risk For AD

Middle-aged individuals who have sleep apnea or who get 9 or more hours of sleep at night have more than double the risk of developing Alzheimer’s […]
July 31, 2020

Smoking Linked to Increased Risk for Unruptured Aneurysm Smoking Linked to Increased Risk for Unruptured Aneurysm

Women who smoke cigarettes are at increased risk for intracranial aneurysms, new research suggests. In a case-control study of more than 500 women between the ages […]
July 31, 2020

Plasma Exchange ‘Encouraging’ as Novel Alzheimer’s Treatment Plasma Exchange ‘Encouraging’ as Novel Alzheimer’s Treatment

Plasma exchange (PE) with albumin replacement may be effective for slowing down symptoms of Alzheimer’s disease (AD), new research suggests. Results from the phase 2b/3 AMBAR […]
July 30, 2020

Positive Phase 3 Topline Results for Migraine Prevention Drug Positive Phase 3 Topline Results for Migraine Prevention Drug

The novel, orally administered calcitonin gene-related peptide (CGRP) antagonist atogepant has met the primary endpoint in a Phase 3 trial for migraine prevention, AbbVie, the company […]
July 30, 2020

Flu Vaccine Protective Against Stroke, CV Events? Flu Vaccine Protective Against Stroke, CV Events?

The rate of seasonal flu vaccination among high-risk groups in the United States, such as those older than 50 years and nursing home residents, is extremely low. However, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0